Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition

被引:11
|
作者
Al-Warhi, Tarfah [1 ]
Abualnaja, Matokah [2 ]
Abu Ali, Ola A. [3 ]
Alyamani, Najiah M. [4 ]
Elsaid, Fahmy G. [5 ,6 ]
Shati, Ali A. [5 ]
Albogami, Sarah [7 ]
Fayad, Eman [7 ]
Abu Almaaty, Ali H. [8 ]
Mohamed, Khaled O. [9 ]
Alamoudi, Wael M. [10 ]
Zaki, Islam [11 ]
机构
[1] Princess Nourah Bint Abdulrahman Univ, Coll Sci, Dept Chem, POB 84428, Riyadh 11671, Saudi Arabia
[2] Umm Al Qura Univ, Fac Appl Sci, Dept Chem, Makkah Al Mukarrama 24381, Saudi Arabia
[3] Taif Univ, Coll Sci, Dept Chem, POB 11099, Taif 21944, Saudi Arabia
[4] Univ Jeddah, Coll Sci, Biol Dept, Jeddah 23218, Saudi Arabia
[5] King Khalid Univ, Coll Sci, Biol Dept, Abha 61421, Saudi Arabia
[6] Mansoura Univ, Fac Sci, Zool Dept, Mansoura 35516, Egypt
[7] Taif Univ, Fac Sci, Dept Biotechnol, POB 11099, Taif 21944, Saudi Arabia
[8] Port Said Univ, Fac Sci, Zool Dept, Port Said 42526, Egypt
[9] Cairo Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Cairo 11562, Egypt
[10] Umm Al Qura Univ, Fac Appl Sci, Dept Biol, Makkah Al Mukarrama 24382, Saudi Arabia
[11] Port Said Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Port Said 42526, Egypt
来源
SYMMETRY-BASEL | 2022年 / 14卷 / 09期
关键词
Z-configurated isomers; thiazole; hydrazinecarbothioamide; phenacylbromide; cytotoxicity; VEGFR-2; apoptosis; p53; mitochondrial membrane potential (MMP);
D O I
10.3390/sym14091814
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Z-configurated isomers are kinetically preferred molecules. Compounds with Z-configuration are contained in many natural products, biologically active compounds and as synthons for organic synthesis. Two series of new thiazole-based analogs were synthesized from appropriate starting materials hydrazinecarbothioamide derivatives (Z)-2a,b to be evaluated for their inhibitory activity towards VEGFR-2. The prepared thiazole compounds 3a-5b were screened for their cytotoxic potency against the MDA-MB-231 breast cancer cell line and their percentage inhibition against VEGFR-2. Compound 4d exhibited good VEGFR-2 inhibitory activity. A DNA flow cytometry analysis was conducted, and compound 4d demonstrated cell cycle arrest at the G1 and G2/M phases of the cell cycle profile and an apoptosis-inducing effect by increasing the percentage of pre-G1 phase. Compound 4d was further evaluated for its apoptosis-inducing effect by studying the effect on mitochondrial membrane potential (MMP) and p53 activation. It was found to boost the level of p53 and reduce the level of MMP compared with the untreated control cells.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, in vitro, and in silico studies
    Yousef, Reda G.
    Eissa, Ibrahim H.
    Elkady, Hazem
    Eldehna, Wagdy M.
    Mehany, Ahmed B. M.
    Nabeeh, Ahmed
    Ibrahim, Ibrahim M.
    Elwan, Alaa
    El-Zahabi, Mohamed Ayman
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (04): : 2120 - 2137
  • [2] Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR-2
    Abd Elhameed, Alaa A.
    Ali, Ahmed R.
    Ghabbour, Hazem A.
    Bayomi, Said M.
    El-Gohary, Nadia S.
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (08) : 1664 - 1698
  • [3] Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors
    Zeidan, Mohamed A.
    Mostafa, Amany S.
    Gomaa, Rania M.
    Abou-zeid, Laila A.
    El-Mesery, Mohamed
    El-Sayed, Magda A. -A.
    Selim, Khalid B.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 168 : 315 - 329
  • [4] Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR-2 and DNA gyrase inhibition, and in silico studies
    Emam, Soha H.
    Hassan, Rasha A.
    Osman, Eman O.
    Hamed, Mohammed I. A.
    Abdou, Amr M.
    Kandil, Mai M.
    Elbaz, Eman Maher
    Mikhail, Demiana S.
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (03) : 433 - 457
  • [5] New thienopyrimidine-based derivatives: Design, synthesis, and biological evaluation as potent anticancer agents and VEGFR-2 inhibitors
    Farag, Myrna A.
    Kandeel, Manal M.
    Kassab, Asmaa E.
    Faggal, Samar I.
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1334
  • [6] Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
    Elmeligie, Salwa
    Aboul-Magd, Asmaa M.
    Lasheen, Deena S.
    Ibrahim, Tamer M.
    Abdelghany, Tamer M.
    Khojah, Sohair M.
    Abouzid, Khaled A. M.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 1347 - 1367
  • [7] Design, Synthesis, and Anticancer Activity of New Quinazoline Derivatives as VEGFR-2 Inhibitors and Apoptosis Inducers
    Ahmed, Marwa F.
    Santali, Eman Y.
    Alsantali, Reem I.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (10) : 2047 - 2057
  • [8] Design, Synthesis, and Anticancer Activity of New Quinazoline Derivatives as VEGFR-2 Inhibitors and Apoptosis Inducers
    Marwa F. Ahmed
    Eman Y. Santali
    Reem I. Alsantali
    Russian Journal of General Chemistry, 2022, 92 : 2047 - 2057
  • [9] Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screeningt
    Patel, Harun M.
    Bari, Pankaj
    Karpoormath, Rajshekhar
    Noolvi, Malleshappa
    Thapliyal, Neeta
    Surana, Sanjay
    Jain, Pritam
    RSC ADVANCES, 2015, 5 (70) : 56724 - 56771
  • [10] Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study
    Alanazi, Mohammed M.
    Elkady, Hazem
    Alsaif, Nawaf A.
    Obaidullah, Ahmad J.
    Alanazi, Wael A.
    Al-Hossaini, Abdulah M.
    Alharbi, Madhawi A.
    Eissa, Ibrahim H.
    Dahab, Mohammed A.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1253